Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Risperidone in Clozapine-Treated Schizophrenia
NCT00056498Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- Dec 2001
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in schizophrenia, schizoaffective disorder, sponsored by University of Maryland, Baltimore. Started Dec 2001; status: completed.
02
Drugs
risperidone
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00056498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056498.